Publications & Patents
HOMEPublications & Patents
Publications & Patents
LyseNTech Patents List
Lysentech / 2020-10-13
| No. | Title | Application number | Authority | Application date | Status |
| LNT001 | Bacteriphage of Pseudomonas aeruginosa and uses thereof | 10-1382893 | KR | 2014.04.01 | Granted |
| LNT002 | Bacteriophage of Salmonella enterica and uses thereof | 10-1449417 | KR | 2014.10.02 | Granted |
| LNT003 | Composition for infecting bacteria resistant to bacteriophage infection comprising bacteriophage PBECO4 or CEA derived there from and its use | 10-1607395 | KR | 2016.03.23 | Granted |
| LNT004 | Bacteriophage of PA7 of Pseudomonas aeruginosa | 10-1612607 | KR | 2016.04.07 | Granted |
| LNT005 | Composition and method of increasing production of bacteriophage by use of Reactive oxygen species | 10-1909831 | KR | 2018.10.12 | Granted |
| LNT006 | Bacteriophage of Klebsiella pneumoniae and uses thereof | 10-2019-0022686 | KR | 2019.02.26 | Applied |
| LNT007 | Bacteriophage of Pseudomonas aeruginosa and uses thereof | 10-2019-0117450 | KR | 2019.09.24 | Applied |
| LNT008 | Novel Polypeptide and Antibiotics against Enterococcus spp. Bacteria Comprising the Polypeptide | 10-2224896 | KR | 2021.03.02 | Granted |
| LNT009 | Novel Polypeptide and Antibiotics against Gram-Negative Bacteria Comprising the Polypeptide | 10-2224897 | KR | 2021.03.02 | Granted |
| LNT010 | Polypeptide Variants and Antibiotics against Gram-Negative Bacteria Comprising the Same | 10-2228999 | KR | 2021.03.11 | Granted |
| LNT011 | Fusion Polypeptides and Antibiotics against Gram-Negative Bacteria Comprising the Same | 10-2286544 | KR | 2021.07.30 | Granted |
| LNT012 | Polypeptides, Fusion polypeptide, and Antibiotic against Gram-negative bacteria comprising same | PCT/KR2021/006302 | PCT | 2021.05.20 | Applied |
| LNT013 | Novel Polypeptides and Antibiotics against Gram-Negative Bacterium Comprising the same | 10-2534221 | KR | 2023.05.15 | Granted |
| LNT014 | Composition and method for increasing production of bacteriophage, using reactive oxygen species | EP 3677671 A1 | EU | 2024.08.21 | Granted |
| LNT015 | Composition and method for increasing production of bacteriophage, using reactive oxygen species | US 11,898,171 | US | 2024.02.13 | Granted |
| LNT016 | Novel polypeptides, fusion polypeptide, and antibiotic against Gram-Negative Bacteria comprising same | US 11,807,881 | US | 2023.11.07 | Granted |
| LNT017 | Novel polypeptides, fusion polypeptide, and antibiotic against Gram-Negative bacteria comprising same | EP 21809334.2 | EU | 2026.02.14 | Granted |
| LNT018 | Novel polypeptides and Antibiotics against Gram-Negative Bacterium Comprising the same | PCT/KR2022/012373 | PCT | 2022.08.18 | Applied |
| LNT019 | Novel polypeptides and Antibiotics against Gram-Negative Bacterium Comprising the same | US 17/820,316 | US | 2022.08.17 | Applied |
| LNT020 | Polypeptides and antibiotics against Gram-negative bacterium comprising the same | ZL 202210999482.0 | CN | 2023.11.10 | Granted |
| LNT021 | Novel polypeptides and Antibiotics against Gram-Negative Bacterium Comprising the same | EP 22191276.9 | EU | 2022.08.19 | Applied |
| LNT022 | Novel polypeptides, fusion polypeptide, and antibiotic against Gram-Negative bacteria comprising same | ZL 202180018132.5 | CN | 2023.02.10 | Granted |
| LNT023 | Novel polypeptides, fusion polypeptide, and antibiotic against Gram-Negative bacteria comprising same | IN 202247062244 | IN | 2022.11.01 | Applied |
| LNT024 | Novel polypeptides, fusion polypeptide, and antibiotic against Gram-Negative bacteria comprising same | CA 3,184,447 | CA | 2022.11.21 | Applied |
| LNT025 | Novel polypeptides, fusion polypeptide, and antibiotic against Gram-Negative bacteria comprising same | JP 7584162 | JP | 2024.11.07 | Granted |
| LNT026 | Oncolytic T7 bacteriophage having cytokine gene and displaying homing peptide on capsid and its use for treating cancer | US 11,384,338 | US | 2022.07.12 | Granted |
| LNT027 | Novel polypeptides and antibiotics against Gram-negative bacterium comprising the same | US 12,102,667 | US | 2024.10.01 | Granted |
| LNT028 | Novel polypeptides and antibiotics against Gram-negative bacterium comprising the same | IN 202447017048 | IN | 2024.03.09 | Applied |